SCHEMBL2204033

SCHEMBL2204033

Clc1ccccc1N1C[C@@H]2C[C@H]1C[N]2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.36
ADRB1 P08588 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HTT P42858 1/20 0.35
MGLL Q99685 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
DRD2 P14416 2/20 0.32
DRD4 P21917 2/20 0.32
CNR1 P21554 1/20 0.31
ALOX5 P09917 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PLA2G1B P04054 1/20 0.31
RAB9A P51151 1/20 0.31
ATG4B Q9Y4P1 1/20 0.31
POLB P06746 1/20 0.31
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31
ADRA1B P35368 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4770959 1.00 NOTUM (0.36) NOTUMADRB1MEN1KMT2AHTT
SCHEMBL2203469 0.72 HTR2A (0.40) NOTUMADRB1KMT2AHTTMGLL
SCHEMBL2205256 0.67 DRD2 (0.36) NOTUMHTTDRD2DRD4ALDH1A1
SCHEMBL3121382 0.66 MAPT (0.43)
SCHEMBL5495222 0.65 SIGMAR1 (0.42) DRD2DRD4
SCHEMBL219341 0.60 ADRB1 (0.59) NOTUMADRB1MEN1KMT2AHTT
SCHEMBL28396664 0.59 ADRB1 (0.71) ADRB1HTTDRD2DRD4KDM4E
SCHEMBL27034876 0.59 NOTUM (0.54) NOTUMADRB1HTTDRD2DRD4
SCHEMBL22210381 0.57 ADRB1 (0.44) NOTUMADRB1HTTDRD2DRD4
SCHEMBL24034719 0.57 MGLL (0.62) ADRB1MEN1KMT2AMGLLALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 EP disclosed
US-7977374-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-12 US disclosed
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-06-18 US disclosed
EP-1926721-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-06-04 EP disclosed
WO-2007029035-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC2, HDAC11 NOTUM 1488/4885ADRB1 3170/4885MEN1 4272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.